Atlas Trials

Zevalin Twice in Aggressive Non-Hodgkin Lymphoma

Clinical trial NCT00902525 · TERMINATED

Trial details

NCT number
NCT00902525
Sponsor
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Diffuse Large B-Cell Lymphoma
Start date
2008-01-01
Primary completion
2009-01-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.